Starbucks (SBUX) Stock Dips While Market Gains: Key Facts

Starbucks (SBUX) recently underperformed the broader market, with its stock declining 1.21% daily and 2.89% monthly. The company faces a challenging outlook, as upcoming quarterly earnings are projected to fall 28.75% year-over-year to $0.57 per share, despite an expected 3.83% revenue increase to $9.42 billion, with full-year EPS also forecast to decline significantly. Analyst sentiment reflects this, with a 1.29% downward revision in EPS estimates and a Zacks Rank of #4 (Sell), while SBUX trades at a substantial valuation premium with a Forward P/E of 39.29 and PEG ratio of 5.15, both significantly above its underperforming industry averages.

Analysis

Starbucks (SBUX) is exhibiting significant weakness relative to the broader market and its sector, evidenced by a 1.21% daily decline against the S&P 500's 0.41% gain and a 2.89% loss over the past month. The negative outlook is reinforced by forward-looking estimates for its upcoming financial release, which project a sharp 28.75% year-over-year contraction in earnings per share to $0.57. This expected profitability decline is particularly concerning as it contrasts with a projected 3.83% increase in revenue, suggesting significant margin pressure. The full-year forecast extends this bearish trend, with consensus estimates pointing to a 34.14% drop in EPS. Analyst sentiment has soured, reflected in a 1.29% downward revision to the consensus EPS estimate over the last month and a Zacks Rank of #4 (Sell). Compounding these fundamental issues, SBUX trades at a steep valuation premium, with a Forward P/E of 39.29 and a PEG ratio of 5.15, both substantially above the industry averages of 23.58 and 2.32, respectively. This valuation appears disconnected from the company's deteriorating earnings growth profile and its position within a poorly-ranked industry.

Key Decisions for Investors

• Investors should be cautious of the stock's high valuation, as its Forward P/E of 39.29 and PEG ratio of 5.15 are not justified by the projected 28.75% year-over-year decline in quarterly earnings.
• Given the stock's demonstrated underperformance, downward analyst estimate revisions, and a formal 'Sell' rating, initiating or adding to long positions carries elevated risk ahead of the earnings report.
• It is critical to monitor the upcoming earnings release for any management guidance that addresses the significant margin compression implied by the divergence between revenue growth and declining profitability.
• Consider the stock's weak relative strength and poor industry ranking (bottom 20%) as potential indicators of continued downward momentum, making it a candidate for underweighting within a diversified portfolio.